Multicenter, randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and safety of donepezil versus placebo in mild cognitive impairment associated with Parkinson's disease - Trial 2022-001751-17
Access comprehensive clinical trial information for 2022-001751-17 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau and is currently Ongoing. The study focuses on Parkinson's disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau
Instituto de Salud Carlos III
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Parkinson's Disease-Cognitive Rating Scale (PD-CRS):
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2022-001751-17
Non-Device Trial